Search

Your search keyword '"Bassetti M"' showing total 2,280 results

Search Constraints

Start Over You searched for: Author "Bassetti M" Remove constraint Author: "Bassetti M"
2,280 results on '"Bassetti M"'

Search Results

152. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

153. Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study

154. The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients

156. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

158. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial (Nature Medicine, (2021), 27, 10, (1752-1760), 10.1038/s41591-021-01499-z)

159. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

160. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group

161. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

162. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

163. Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis

164. Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections

165. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

166. Mapping the human genetic architecture of COVID-19

167. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

168. Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study

169. Electrochemical, in silico and time-resolved EPR behaviour of semiconductive π-conjugated poly(p-phenyleneethynylenevinylene)s (PPEV)

170. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study

171. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

172. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

173. First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

174. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

175. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

176. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

177. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

179. International Validation of a Methicillin-Resistant Staphylococcus aureusRisk Assessment Tool for Skin and Soft Tissue Infections

181. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

182. The burden of severe cases of Influenza disease: The Friuli Venezia Giulia Region experience

183. Contesto morfo-sedimentario olocenico e processi naturali di formazione del sito

189. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

190. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

191. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

192. New record of dust input and provenance during glacial periods in western australia shelf (IODP expedition 356, site U1461) from the middle to late pleistocene

193. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

194. Corrigendum to 'Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 Era (PPE-SAFE): An international survey' [Journal of Critical Care, Volume 59, October 2020, Pages 70–75] (Journal of Critical Care (2020) 59 (70–75), (S088394412030592X), (10.1016/j.jcrc.2020.06.005))

195. Switching from TDF to TAF or dual therapy (DT)-based regimens in HIV-infected individuals with viral load <= 50 copies/ml: does eGFR matter?

196. The interplay between acute bacterial skin and skin structure infections and depression: a vicious circle of major clinical importance

198. Premessa

199. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis

200. Diagnosing COVID-19-associated pulmonary aspergillosis

Catalog

Books, media, physical & digital resources